Aims The economic value of transcatheter aortic valve replacement (TAVR) in low surgical
risk patients with severe, symptomatic aortic stenosis is not known. Our objective was to …

Background—In patients with severe aortic stenosis who cannot have surgery, transcatheter
aortic valve replacement (TAVR) has been shown to improve survival and quality of life …

Background: In patients with severe symptomatic aortic stenosis at low surgical risk,
transfemoral transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 valve has …

Background Recent studies have shown that transcatheter aortic valve implantation (TAVI) is
non-inferior to surgical aortic valve replacement (SAVR) for treatment of low-risk patients …

Background: Previous studies of the cost-effectiveness of transcatheter aortic valve
replacement (TAVR) have been based primarily on a single balloon-expandable system …

Objective To determine the cost-effectiveness of transcatheter aortic valve implantation
(TAVI) compared with surgical aortic valve replacement (SAVR) in a high-risk aortic stenosis …

Background A recent clinical trial showed that self-expandable transcatheter aortic valve
replacement (TAVR) was non-inferior to surgical aortic valve replacement (SAVR). However …

Background: In patients with severe aortic stenosis (AS) at intermediate surgical risk,
treatment with transcatheter aortic valve replacement (TAVR) or surgical aortic valve …

Background: In patients with severe aortic stenosis, treatment with transcatheter aortic valve
replacement (TAVR) has been shown to be cost-effective in the high-risk surgical population …

Objectives: The aim of this study was to evaluate the cost-effectiveness of transcatheter
aortic valve replacement (TAVR) compared with surgical aortic valve replacement (AVR) for …